Striking the right balance with type I interferon signalling in cancer.
Saved in:
| Title: | Striking the right balance with type I interferon signalling in cancer. |
|---|---|
| Authors: | Chadwick TB; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., So J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia.; Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hertzog PJ; Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Clayton, Victoria, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Victoria, Australia., Haynes NM; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. nicole.haynes@petermac.org.; Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. nicole.haynes@petermac.org., Parker BS; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, Australia. belinda.parker@petermac.org.; Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. belinda.parker@petermac.org. |
| Source: | Nature reviews. Cancer [Nat Rev Cancer] 2026 Jun; Vol. 26 (6), pp. 391-414. Date of Electronic Publication: 2026 Mar 23. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
